HCAT
HCAT
Health Catalyst, Inc.Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $74.68M ▼ | $-46.83M ▼ | $-91.03M ▼ | -121.89% ▼ | $-1.28 ▼ | $44.65M ▲ |
| Q3-2025 | $76.32M ▼ | $55.33M ▼ | $-22.23M ▲ | -29.12% ▲ | $-0.32 ▲ | $-3.94M ▲ |
| Q2-2025 | $80.72M ▲ | $75.33M ▲ | $-40.98M ▼ | -50.76% ▼ | $-0.59 ▼ | $-22.43M ▼ |
| Q1-2025 | $79.41M ▼ | $56.41M ▲ | $-23.74M ▼ | -29.9% ▼ | $-0.35 ▼ | $-3.89M ▼ |
| Q4-2024 | $79.61M | $52.19M | $-20.67M | -25.97% | $-0.33 | $-2.48M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $95.73M ▲ | $502.64M ▼ | $256.86M ▲ | $245.78M ▼ |
| Q3-2025 | $91.54M ▼ | $587.13M ▼ | $255.21M ▼ | $331.92M ▼ |
| Q2-2025 | $97.34M ▼ | $616.18M ▼ | $268.63M ▼ | $347.55M ▼ |
| Q1-2025 | $341.97M ▼ | $891.54M ▲ | $514.73M ▲ | $376.81M ▲ |
| Q4-2024 | $392M | $858.93M | $493.72M | $365.21M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-91.03M ▼ | $9.91M ▲ | $1.01M ▲ | $-434K ▲ | $10.51M ▲ | $9.64M ▲ |
| Q3-2025 | $-22.23M ▲ | $-464K ▲ | $-9.35M ▲ | $-537K ▲ | $-10.41M ▲ | $-5.27M ▲ |
| Q2-2025 | $-40.98M ▼ | $-9M ▼ | $-52.23M ▼ | $-230.1M ▼ | $-291.26M ▼ | $-8.77M ▼ |
| Q1-2025 | $-23.74M ▼ | $280K ▲ | $96.76M ▲ | $-4.71M ▼ | $92.32M ▲ | $-390K ▲ |
| Q4-2024 | $-20.67M | $-3.53M | $-112.75M | $37.69M | $-78.68M | $-8.36M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Recurring Technology | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Health Catalyst, Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a strong liquidity and net cash position, a healthy gross margin structure, and a differentiated healthcare analytics platform supported by deep domain expertise and high switching costs. The company’s technology roadmap, especially the Ignite platform and AI integration, aligns well with long-term trends toward data-driven healthcare and measurable performance improvement. Its blend of software and services helps embed it deeply in client operations and supports long-term relationships.
The most significant risks are persistent operating and net losses, only modest positive operating cash flow, and ongoing cash burn when acquisitions and capital returns are considered. Heavy reliance on goodwill and other intangibles could lead to write-downs if growth or profitability falls short. Competitive pressures from large electronic health record vendors, other analytics specialists, and big technology firms, combined with the possibility of clients building in-house solutions, add strategic risk. If financial performance does not improve, the company may face tougher choices about spending, acquisitions, or raising additional capital.
The overall outlook is that of a company with attractive strategic positioning and technology, but with execution and financial hurdles still to clear. Success will likely depend on completing the transition to the Ignite platform, demonstrating consistent margin improvement, and showing that innovation in AI and analytics can translate into scalable, profitable growth. As long as liquidity remains strong, the firm has room to pursue this path, but the window is not unlimited, making the next few years particularly important for validating its long-term business model.
About Health Catalyst, Inc.
https://www.healthcatalyst.comHealth Catalyst, Inc. provides data and analytics technology and services to healthcare organizations.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q4-2025 | $74.68M ▼ | $-46.83M ▼ | $-91.03M ▼ | -121.89% ▼ | $-1.28 ▼ | $44.65M ▲ |
| Q3-2025 | $76.32M ▼ | $55.33M ▼ | $-22.23M ▲ | -29.12% ▲ | $-0.32 ▲ | $-3.94M ▲ |
| Q2-2025 | $80.72M ▲ | $75.33M ▲ | $-40.98M ▼ | -50.76% ▼ | $-0.59 ▼ | $-22.43M ▼ |
| Q1-2025 | $79.41M ▼ | $56.41M ▲ | $-23.74M ▼ | -29.9% ▼ | $-0.35 ▼ | $-3.89M ▼ |
| Q4-2024 | $79.61M | $52.19M | $-20.67M | -25.97% | $-0.33 | $-2.48M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q4-2025 | $95.73M ▲ | $502.64M ▼ | $256.86M ▲ | $245.78M ▼ |
| Q3-2025 | $91.54M ▼ | $587.13M ▼ | $255.21M ▼ | $331.92M ▼ |
| Q2-2025 | $97.34M ▼ | $616.18M ▼ | $268.63M ▼ | $347.55M ▼ |
| Q1-2025 | $341.97M ▼ | $891.54M ▲ | $514.73M ▲ | $376.81M ▲ |
| Q4-2024 | $392M | $858.93M | $493.72M | $365.21M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2025 | $-91.03M ▼ | $9.91M ▲ | $1.01M ▲ | $-434K ▲ | $10.51M ▲ | $9.64M ▲ |
| Q3-2025 | $-22.23M ▲ | $-464K ▲ | $-9.35M ▲ | $-537K ▲ | $-10.41M ▲ | $-5.27M ▲ |
| Q2-2025 | $-40.98M ▼ | $-9M ▼ | $-52.23M ▼ | $-230.1M ▼ | $-291.26M ▼ | $-8.77M ▼ |
| Q1-2025 | $-23.74M ▼ | $280K ▲ | $96.76M ▲ | $-4.71M ▼ | $92.32M ▲ | $-390K ▲ |
| Q4-2024 | $-20.67M | $-3.53M | $-112.75M | $37.69M | $-78.68M | $-8.36M |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|
Recurring Technology | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ | $50.00M ▲ |
Q4 2025 Earnings Call Summary
Read Call Summary5-Year Trend Analysis
A comprehensive look at Health Catalyst, Inc.'s financial evolution and strategic trajectory over the past five years.
Key strengths include a strong liquidity and net cash position, a healthy gross margin structure, and a differentiated healthcare analytics platform supported by deep domain expertise and high switching costs. The company’s technology roadmap, especially the Ignite platform and AI integration, aligns well with long-term trends toward data-driven healthcare and measurable performance improvement. Its blend of software and services helps embed it deeply in client operations and supports long-term relationships.
The most significant risks are persistent operating and net losses, only modest positive operating cash flow, and ongoing cash burn when acquisitions and capital returns are considered. Heavy reliance on goodwill and other intangibles could lead to write-downs if growth or profitability falls short. Competitive pressures from large electronic health record vendors, other analytics specialists, and big technology firms, combined with the possibility of clients building in-house solutions, add strategic risk. If financial performance does not improve, the company may face tougher choices about spending, acquisitions, or raising additional capital.
The overall outlook is that of a company with attractive strategic positioning and technology, but with execution and financial hurdles still to clear. Success will likely depend on completing the transition to the Ignite platform, demonstrating consistent margin improvement, and showing that innovation in AI and analytics can translate into scalable, profitable growth. As long as liquidity remains strong, the firm has room to pursue this path, but the window is not unlimited, making the next few years particularly important for validating its long-term business model.

CEO
Benjamin Albert
Compensation Summary
(Year 2024)
Upcoming Earnings
ETFs Holding This Stock
Summary
Showing Top 3 of 71
Ratings Snapshot
Rating : C+
Most Recent Analyst Grades
Wells Fargo
Equal Weight
Canaccord Genuity
Buy
Stephens & Co.
Equal Weight
Cantor Fitzgerald
Neutral
Citigroup
Neutral
Stifel
Hold
Grade Summary
Showing Top 6 of 10
Price Target
Institutional Ownership
FIRST LIGHT ASSET MANAGEMENT, LLC
Shares:13.44M
Value:$16.59M
BLACKROCK, INC.
Shares:5.5M
Value:$6.8M
BLACKROCK INC.
Shares:5.43M
Value:$6.71M
Summary
Showing Top 3 of 192

